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ABSTRACT 
Insulin secretory granules (SGs) mediate the regulated secretion of insulin, which 
is essential for glucose homeostasis. The basic machinery responsible for this regulated 
exocytosis consists of specific membrane proteins present both at the plasma membrane 
and on insulin SGs. The protein composition of insulin SGs thus dictates their release 
properties, yet the mechanisms controlling insulin SG formation, which determines this 
molecular composition, remain poorly understood. VPS41, a component of the 
endolysosomal tethering HOPS complex, was recently identified as a cytosolic factor 
involved in the formation of neuroendocrine/neuronal granules. We now find that a stable 
pool of VPS41 exists outside of HOPS and is required for regulated insulin secretion. 
Loss of VPS41 leads to a reduction in insulin SG number and changes in their 
transmembrane protein composition, associated with defects in granule release properties. 
We further show that a human point mutation, identified in patients with neurological 
defects but no endocrine defects, enables isolation of the HOPS independent function of 
VPS41. Finally, we report that mice with a deletion of VPS41 specifically in β-cells 
develop a diabetic phenotype due to a defect in insulin secretion. Altogether our data 
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Intracellular trafficking to the plasma membrane and extracellular space occurs 
primarily through a single mechanism of action, the constitutive pathway, by which 
proteins move from the ER to the Golgi network, bud in vesicles and are delivered to the 
surface in an unregulated manner (Resa et al, 1987). However, in specialized 
neuroendocrine cell types, such as neurons and pancreatic β-cells, there exist a second 
pathway by which they can regulate the intracellular storage and stimulated release of 


















Figure 1: The constitutive and regulated secretory pathways. The constitutive pathway 
ensures disposal of cellular metabolites as well as delivery of new lipids and proteins to 
plasma membrane. The regulated secretory pathway take place only in specialized cell 
types, where dense protein aggregate containing vesicles can be stored intracellularly 
and released upon exterior cellular stimulus. (Molecular Biology of the Cell. 4th 
edition. Alberts B, Johnson A, Lewis J, et al. New York; 2002) 
 
These secretory granules (SGs) form at the trans-Golgi network (TGN), where they bud 
as immature secretory granules, which need further processing to be competent for 
regulated release (Resa et al, 1987, Tooze, 1998). 
These specialized post-Golgi compartments, known as secretory granules (SGs) 
or large dense-core vesicles (LDCVs), have transmembrane and peripheral membrane 
cargos that are important for regulating the maturation, transport, and regulated release 
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(SNARE complexes). SGs also contain a set of soluble protein cargos like peptide 
hormones, such as insulin, and enzymes that process these hormones into their mature 
and active form (Tooze 1998). These vesicles then undergo a series of maturation steps, 
including lumenal acidification, via v-ATPase association, processing and hormone 
aggregation, which relies on granule acidification, and removal of immature granule 
markers (e.g., syntaxin 6, vamp4) (Kogel et al, 2010; Sun-Wada et al, 2006; Klumperman 
et al, 1998; Hinners et al, 2003). Surprisingly, the exact mechanisms dictating SG 
biogenesis and maturation, which is thought to determine their molecular composition, 
remains poorly understood. The proper temporal release of these peptide hormones plays 
a critical role in the body’s ability to maintain homeostasis. Pancreatic β-cells, for 
example, produce insulin and store it within these intracellular SGs. At any given time, 
these cells can accumulate thousands of insulin SGs, and these vesicles only undergo 
exocytosis only in response to an extracellular stimulus (e.g., hyperglycemia) (Rorsman 
et al 2012). The basic machinery responsible for this regulated exocytosis consists of 
proteins present both at the plasma membrane and on insulin SGs. Thus, the final protein 
composition of SGs partly dictates their release properties.  
Insulin and the counter-regulatory hormone, glucagon, are potent regulators of 
blood glucose homeostasis. The cells regulating the production and release of these 
hormones, are found within the islets of the pancreas. Insulin containing SGs are secreted 
from the β-cells and glucagon from α-cells, which together make up greater than 80% of 
the total cellular mass of the islet, and these two hormones regulate systemic blood 
glucose levels within a very narrow window (Roder et al 2016). This preservation of 
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blood glucose homeostasis is controlled by regulated release of these two hormones, 
glucagon and insulin, in response to changing blood glucose levels (Fig 2). Glucagon is 
released from α-cells in response to fasting blood glucose, to stimulate gluconeogenesis 
and downstream increases in blood glucose levels. Insulin, which antagonizes the 
function of glucagon, is released in response to increased blood glucose levels, such as 
those that occur post-feeding, and promotes storage of glucose through glycogenesis.  
In β-cells the main stimulus for release of insulin, elevated blood glucose, is 
mediated through uptake of excess glucose from the blood by the GLUT2 glucose 
transporter. This increased intracellular glucose increases the ATP/ADP ratio in the cell 
via glycolysis. The increased ATP production leads to closure of ATP-sensitive K+ 
channels in the cell. K+ build up in the cell, due to inhibited export, induces membrane 
depolarization and opening of voltage-gated Ca2+ channels, leading to a downstream 
increase in intracellular Ca2+ concentration, which eventually induces the regulated 





Figure 2: Maintenance pathway of blood glucose levels by insulin and glucagon. Post-
feeding blood glucose spikes induce insulin release from pancreatic β-cells, which 
decreases gluconeogenesis and stimulates glycogenesis in the liver, as well as 
increasing adipose and muscle glucose uptake to decrease blood glucose levels. Under 
fasting blood glucose conditions, α-cells increase blood glucose levels by increasing 
gluconeogenesis and glycogenolysis in liver to increase blood glucose levels (Roder et 
al 2016).  
 
The regulation of insulin secretion, as well as that of other hormones, needs to be tightly 
regulated to maintain physiological homeostasis. How these hormone-containing SGs 
form has long been a topic of debate, currently there exist two major models for the 
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sorting of cargo leading to the biogenesis of these granules. The “sorting for entry” 
model, which relies on the idea that sorting of soluble dense core vesicle cargo is 
mediated by the aggregation of these cargo together in the slightly acidic TGN lumen 
(Fig. 3). This aggregation of cargo leads to the separation of regulated and constitutive 
cargo into distinct vesicles based solely on the sorting of cargo into these aggregates. 
This hypothesis is attractive because the identification of sorting receptors in the TGN 
and uniform sorting signal sequences on soluble cargo has been difficult. “Sorting for 
entry” is also supported by the aggregation of chromogranin, a regulated secretory cargo, 
aggregate in conditions similar to the TGN lumen, low pH and calcium (Gerdes et al, 
1989), and this has been shown to be sufficient to drive increased sorting and storage of 
hormones, such as POMC (Natori and Huttner, 1996). However, this model does have its 
deficiencies. For example, it has been shown that rate of insulin aggregation increases 
after processing from proinsulin to insulin. There is still significant debate as to when 
processing of insulin, by the proprotein convertases (PC1/3 and PC2), actually occurs. 
Localization of the processing of insulin remains unclear, as studies have shown that this 
process can occur both in the TGN lumen (Xu et al, 1993) as well as post-TGN in 
immature secretory granules (ISGs)(Orci et al, 1987). This might suggest that insulin can 
only end up in a mature SG by being retained in a ISG post-TGN budding, which 
suggests a second model of “sorting by retention”. This model proposes that post-TGN 
compartments are formed that have SG cargo, constitutive cargo, and cargo destined for 
the lysosome (M6PR for example) and that these cargo are then segregated in post-Golgi 
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budding events that sort away constitutive and lysosomal cargos into a distinct classes of 




Figure 3: Models of secretory granule biogenesis. “Sorting by entry” model indicates 
that cargo forms aggregates within the TGN lumen and is separated from constitutive, 
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unaggregated cargo, by virtue of this aggregation. “Sorting by retention” model 
suggests that cargo is unaggregated and is budded from the TGN in bulk along with 
constitutive cargo, which is later budded off into constitutive vesicles as the regulated 
cargo begins to condense in the acidifying vesicle. (Tooze 1998) 
 
secretory cargo is aggregating to form the well characterized dense-core of a mature 
secretory granule (Arvan and Castle 1998). There is still a lot that is unknown about how 
these models might be separate or acting in concert with one another. Additionally, the 
possibility exists that these models are each true in different cell types dependent on the 
host of secretory cargo expressed in these cells (Thiele et al, 1997). 
However, the biogenesis of secretory granules is not limited to luminal TGN 
interactions with the secretory cargo itself. Recently, many cytosolic components have 
been implicated in the formation and maturation of SGs, and that includes BAR domain-
containing proteins (Arfaptin-1, Pick1, and ICA69), Rab proteins (Rab-2, Rab-5 and Rab-
10), as well as Rab-2 effectors (Ailion et al., 2014; Cao et al., 2013; Edwards et al., 2009; 
Erlendsson et al., 2014; Gehart et al., 2012; Hannemann et al., 2012; Holst et al., 2013; 
Pinheiro et al., 2014; Sasidharan et al., 2012; Sumakovic et al., 2009; Hummer et al, 
2017). For example, it was recently shown that PICK1, a bar domain containing protein 
involved in cellular trafficking associates with ISGs and disruption of its function leads to 
impaired granule storage and morphology in adrenal chromaffin cells without effecting 
the release properties of the remaining granules (Pinheiro et al, 2014). Disruption of AP3, 
an adaptor protein involved in trafficking from endosomes and the TGN, also decreases 
secretory cargo content. AP3 disruption affects the sorting and/or retention of regulated 
transmembrane secretory cargo (such as VMAT2), which influences their exocytosis 
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properties (Asensio et al, 2010). Although these factors have been proposed to influence 
SG formation, their exact mechanism of action remained to be determined. In particular, 
the spatial-temporal resolution of the cytosolic events controlling sorting, budding and 
maturation is not well understood. 
         VPS41/Vam2p and VPS39/Vam6p associate with the VPS Class C core proteins 
(VPS11, VPS16, VPS18 and VPS33) to form the homotypic fusion and vacuole protein 
sorting (HOPS) complex, which acts as a tether for mediating heterotypic late endosome-
lysosome, and autophagosome-lysosome fusion (Balderhaar and Ungermann, 2013; 
Nakamura et al, 1997). Disruption in HOPS impairs delivery of endocytic cargo to 
lysosome and causes defects in autophagosome clearance (Pols et al, 2013; Jiang et al, 
2014) (Fig. 4). Dysfunction of this pathway has been shown in non-neuroendocrine cell 
types to be directly responsible for several human diseases, including neurodegeneration, 
neuron demyelination, blood platelet granule deficiencies, as well as hypopigmentation 
and vision defects (van der Beek et al, 2019). CORVET, another VPS Class C complex, 
which mediates the homotypic fusion of early endosomes, shares the sample core 
complex as HOPS, however VPS41 and VPS39 are replaced with VPS3 and VPS8. VPS3 
and VPS8 have been recently shown to be able to interact with each other outside of the 
CORVET complex and seem to mediate trafficking from early to recycling endosomes 
(Jonker et al, 2018). This provides reasoning that VPS41 and/or VPS39 may be able to 
have another function outside of the HOPS complex. Independent of its role in HOPS, 
VPS41 has also been shown to function in the formation of TGN-derived LAMP-1 post-
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Golgi carriers (Pols et al, 2013), which have been shown to carry lysosomal cargos in a 




Figure 4: Schematic representation of VPS core complex function within the 
endolysosomal pathway. HOPS function in fusing late endosomes and autophagosomes 
with lysosomes is controlled by the association of HOPS with these compartments as 
they mature, going from Rab5-positive early endosomes to Rab7-late endosome-
lysosomal compartments. VPS41-containing HOPS complex interacts directly with 
Rab7 and other factors on these membranes, to mediate its compartment specificity and 
regulate the fusion of these specific compartments.  
 
Interestingly, gene expression analysis revealed a significant reduction in VPS41 
mRNA levels in islets of a model of mice susceptible to develop diabetes, suggesting that 
it might be a factor contributing to the development of this pathological condition (Keller 
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et al, 2008). In accordance with this, it was recently found that VPS41 also affects 
regulated secretion of peptide hormones and neuropeptides from neuroendocrine cells 
and neurons, independently of its role in the HOPS complex (Asensio et al, 2013). It was 
also shown in this study that VPS41 can directly interact with AP3, which also has a role 
in SG biogenesis (Asensio et al, 2010), as well as itself to form clathrin like structures in 
vitro. This was indicating that VPS41 and AP3 may be acting as the adaptor-coat 
complex in formation of SGs from the TGN. This was additionally supported by the 
presence of VPS41 at the trans-Golgi (Pols et al, 2013), and the presence of VPS41 on 
post-Golgi compartments. Altogether, this led us to hypothesize that VPS41 might be 
contributing to glucose homeostasis by influencing insulin SG biology. Using siRNA and 
CRISPR/Cas9 in INS-1 cells, we now show that a stable pool of VPS41 exists outside of 
the HOPS complex and this pool is required for appropriate insulin storage and secretion. 
The lack of VPS41 affects SG number, morphology and release properties, by 
influencing an early step during SG formation. Finally, we report that mice with a 
deletion of VPS41 specifically in beta-cells are develop a diabetic phenotype due to a 












MATERIALS AND METHODS 
Molecular Biology and Plasmids 
The human codon-optimized Cas9 and chimeric guide RNA expression plasmid 
(pX459v2) developed by the Zhang lab (Cong et al., 2013) were obtained from Addgene. 
To generate gRNA plasmids, a pair of annealed oligos (20 base pairs) were ligated into 
the single guide RNA scaffold of pX459v2. The following gRNAs sequences were used: 
Forward (rat): 5′-CACCGACTCTCAGACTGAGCTATGG-3′; Reverse (rat): 5′-
AAACCCATAGCTCAGTCTGAGAGTC -3′ to generate the INS1 VPS41 KO line. Rat 
VPS41 lentiviral plasmid was generated by amplifying VPS41 from rat cDNA using the 




PCR products were then subcloned by Gibson ligation into pLenti-CMV-GFP-Puro 
(Addgene #17448). The following primers were used to genotype VPS41 KO INS-1 
cells: rVPS41-F: 5′-ATATGGTACCTGCAGAGAGGACTAAACGAGA-3′; rVPS41-R 
5′- ATATGAGCTCATGGACGTTGCCATCCAAGT-3′. To test for the presence of 
indels, the resulting PCR products were ligated into pBlueScript II KS. Isolated plasmids 
from 10 random colonies were then analyzed for the presence of indels by Sanger -
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sequencing. siRNA pools were obtained from Dharmacon (VPS41: 306991, VPS39: 
362199) and used as previously described (Asensio et al 2010, 2013). 
 
Cell Culture and Lentiviral Production 
INS-1 cells were maintained in RPMI supplemented with 10% FBS, 1mM Na-
Pyruvate, 50uM Betamercaptoethanol (BME) under 5% CO2 at 37°C. INS1 were 
transfected using Lipofectamine 2000 or Fugene-HD as per manufacturer’s instructions. 
HEK293T cells were maintained in DMEM supplemented with 10% FBS under 5% CO2 
at 37°C. Lentivirus was produced by transfecting HEK293T cells with pLenti-CMV-
Puro, psPAX2, and pVSVG using 1mg/mL PEI. 
 
RNA Isolation and qPCR Analysis 
RNA was isolated from VPS41 KO or HA-VPS41 INS-1 cells via TriZOL 
extraction as per manufacturer’s instructions (Ambion). Isolated RNA was DNase treated 
with Turbo DNAse (Ambion). A quantity of 2 μg of total RNA was reverse transcribed 
with dT(15) oligo (SuperScriptIV, Thermo) and subjected to triplicate qPCR for the 
target transcripts. qPCR was performed using SYBR Green qPCR Master Mix (BioRad) 
and a BioRad iQ5 real-time PCR machine (BioRad) with gene-specific primers. The 
results were normalized to expression of the housekeeping gene ActB. Primers used in 






Name Sequence Target 
C17-29 CTAGCACCATGAAGATCAAGA rActB Exon5-6 
C17-30 GATCCACATCTGCTGGAAG rActB Exon5-6 
C17-33 CTTTTGTCAAACAGCACCTT rTubb Exon3-4 
C17-34 CAGTGCCAAGGTCTGAAG rTubb Exon3-4 
C19-23 GAACCTGGGACAATGGAC rINS1/2 Exon1-2 
C19-24 TACCGTGAACAAAACTGTCA rINS1/2 Exon1-2 
C19-25 GGTACACTTCCTACAGTGTG CatB Exon8-10 
C19-26 ATGCTTGTATACGCCTGATT CatB Exon8-10 
C19-29 TCCAACTATTCCCTGAAAGC LAMP1 Exon8-9 
C19-30 TCACTTTCTACCCTGAAAGC LAMP1 Exon8-9 
Table A: Primers used for qPCR analysis, primers span exon-intron junctions to ensure 
that it is reading splice RNA only.  
 
Insulin Secretion Assays 
INS-1 insulin secretion was monitored by ELISA (Thermo, ERINS). Cells were 
plated at 200k cells per 24 well. Prior to stimulation, cells were moved to complete media 
containing 5mM glucose 18hrs prior, and to KRB buffer supplemented with 1.5mM 
glucose 2hrs prior and maintained with 5% CO2 at 37°C. Cells were either stimulated in 
250ul KRB supplemented with 40mM KCl and 16.7mM glucose or in low glucose KRB 
for 2hrs. The secreted fraction was removed and spun @1k xg for 5min to remove 
cellular debris. Cells were lysed in 500ul lysis buffer (50mM TRIS-HCl, 300mM NaCl, 
2% v/v TritonX-100) supplemented with 1mM PMSF and 1X protease inhibitor cocktail 
on ice for 5min. Cellular debris removed by spinning at 21k xg for 10min at 4°C. ELISA 
was performed as per manufacturer instructions with the secreted fraction being diluted 
1:2 and the cellular fraction being diluted 1:10. Proinsulin secretion was monitored by 
ELISA (Mercodia). Samples, both cellular and secreted, were diluted 1:2 for the assay. 
Secretion was normalized to cell content by measuring DNA in the cellular 
fraction.  Constitutive secretion from INS-1 VPS41 KO and rescue cells was monitored 
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via secretion of a secretory pathway targeted GFP (ssGFP). VPS41 KO or HA-VPS41 
rescue INS-1 cells were plated in 24 well plate. The next day cells were transfected with 
ss-pHluorin using Fugene as per manufacturer instructions. 48hrs post-transfection, cells 
were washed twice with low glucose KRB buffer. Cells were then incubated 3hrs with 
250ul of low glucose KRB. After cooling on ice 5min, supernatant containing secreted 
ss-pHluorin was removed and spun @1k xg for 5min @4C before being transferred to a 
new tube. Cells were lysed  in 250ul lysis buffer and incubated on ice 5min. Cellular 
debris was removed by spinning lysate @21k xg for 10min. Samples were loaded into 
black walled 96 well plate (GBO) and fluorescent signal was measure using a plate reader 
(Tecan) . Blood insulin and islet insulin secretion ELISA was conducted according to 
manufacturer’s protocol (Crystal Chem Ultra Sensitive Mouse ELISA: 
http://www.crystalchem.com/media/catalog/product/9/0/90080c.pdf) 
 
Immunofluorescence and Spinning Disk Confocal Microscopy 
INS-1 cells were rinsed with PBS and fixed in 4% paraformaldehyde in PBS and 
incubated for 20 min at room temperature. Cells were permeabilized in PBS containing 
0.1% Triton X-100 for 10 min at room temperature and blocked in PBS containing 2% 
BSA, 1% fish skin gelatin, and 0.02% saponin. Primary and secondary antibodies were 
diluted as reported in Table B. Images were acquired using a custom-built Nikon 
spinning disk at a resolution of 512 × 512 pixels with a 63× objective (Oil Plan Apo NA 
1.49) and an ImageEM X2 EM-CCD camera (Hamamatsu, Japan). Localizations were 
found using the detection algorithm as previously described (Jaqaman et al, 
2008).  Localizations were passed to an algorithm that first filtered out spurious noise 
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with a cutoff of sigma=1.58 pixels (330nm).  Distances between both channel’s 
localizations were computed and localizations with a distance d < 1 pixel were deemed 
colocalized.  The relative number of colocalization events versus total localizations for 
LC3-mCherry+ compartments was computed. 
 
Antibody Target Source Dilution (App) 
αVPS41 (mouse) Santa Cruz Biotech. (D-12) 1:100 (Western) 
αTubulin (mouse) DSHB (E-7) 1:500 (Western) 
αActin (mouse) DSHB (JLA20) 1:500 (Western) 
αSynaptophysin (mouse) Synaptic Systems (MMS-618R) 1:2000 (Western) 
PC1/3 (rabbit) Richard Mains (Gift) 1:500 (Western) 
αTFE3  (rabbit) Cell Signaling Tech. (14779) 1:500 (IF) 
αCathepsin D (mouse) Santa Cruz Biotech. (F-12) 1:50 (Western) 
αInsulin (mouse) Sigma Aldrich (K36AC10) 1:1000 (IF) 
αHA (rat) Sigma Aldrich (3F10) 1:1000 (IF) 
Table B: Antibodies used in this study, shown with product number and dilution used 
for specified application. 
 
 
NPY-pHluorin Exocytosis Imaging 
INS-1 cells were co-transfected with NPY-pHluorin and NPY-mCherry. At 1 day 
after transfection, cells were transferred to poly-l-lysine coated 22 mm glass coverslips. 
After an additional 2 days, cells were moved to KRB buffer supplemented with 1.5mM 
glucose 2hr prior to imaging and maintained with 5% CO2 at 37°C. After reset, cells were 
washed with KRB buffer and coverslips were transferred to an open imaging chamber 
(Life Technologies). Cells were imaged close to the coverslips, focusing on the plasma 
membrane (determined by the presence of NPY-mCherry positive plasma membrane 
docked-vesicles), using a custom-built Nikon spinning disk at a resolution of 512 × 512 
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pixels. Images were collected for 100 ms at 10 Hz at room temperature with a 63× 
objective (Oil Plan Apo NA 1.49) and an ImageEM X2 EM-CCD camera (Hamamatsu, 
Japan). Following baseline data collection (15 s), an equal volume of 2x KRB buffer 
containing 114 mM KCl (60mM final) and 32.65mM Glucose (16.7mM final) was added 
to stimulate secretion and cells were imaged for an additional 45 s. At the end of the 
experiment, cells were incubated with KRB solution containing 50 mM NH4Cl, pH 7.4, 
to reveal total fluorescence and to confirm that the imaged cells were indeed transfected. 
Movies were acquired in MicroManager (UCSF) and exported as tif files. Events were 
quantified within the first 10s of basal stimulation and between 10s post stimulation (15s 
after high K+ addition). Event length was calculated based on the time the event 
remained at or above 20% above baseline signal. For fura imaging, Cells were plated 
onto poly-l-lysine (Sigma) coated imaging dishes and allowed to adhere in media for 2 
days. To load FURA-2, AM (Life Technologies), a basal KRB solution with 500nM 
FURA was added to the cells. Cells were incubated in the dark at room temperature for 
30 minutes, the FURA-2, AM solution was removed and cells washed briefly with basal 
solution was added to the dish. Cells were imaged using a CoolSNAP HQ2 camera with 
6.21 µm/pixel using a 40x oil objective (1.3 N.A.). Images were binned (2x2) and cells 
were alternatively excited by 340 nm and 380 nm light every 500 ms with a 100 ms 
interval between exposures. Cells were imaged for 15s under basal conditions prior to 





Density Gradient Fractionation 
Equilibrium sedimentation through sucrose was performed as previously 
described (Asensio et al., 2010, 2013). Briefly, a postnuclear supernatant was prepared 
from INS-1 cells by homogenization with a ball bearing device (12 μm clearance), loaded 
onto a 0.6–1.6 M continuous sucrose gradient, and sedimented at 30,000 rpm in an SW41 
rotor for 14–16 h at 4°C. Fractions (∼750 μl each) were collected from the top and were 
analyzed by quantitative fluorescence immunoblotting using a FluoChem R imager 
(ProteinSimple). Insulin concentration in the fractions was determined by ELISA as 
before, after diluting fraction 1:4 in ELISA lysis buffer for 5min, then diluting sample 1:5 
in ELISA diluent.  
 
EGF Degradation Assay 
INS-1 cells plated on PLL coated glass coverslips, were washed twice with PBS 
and starved of serum for 2 h in DMEM with 0.1% BSA (GoldBio). Following starvation, 
cells were washed twice with ice-cold PBS on ice and incubated with EGF conjugated 
with Alexa-Fluor 647 (ThermoFisher) at a final concentration of 1 μg/ml for 1 h on ice 
taking precautions to protect from light. Excess unbound EGF was removed by washing 
with ice-cold PBS in presence of 0.5% BSA. Cells were chased for indicated times @37C 
before fixation with 4% PFA in PBS for 30 min on ice. Cells were analyzed by spinning 





Mouse Housing and Breeding 
Mice are bred at LAS Facility, Bosch Institute, University of Sydney, Australia 
and transferred to the Charles Perkins Centre, University of Sydney for experimental 
procedures. All mice are fed a standard laboratory chow (13% calories from fat, 65% 




VPS41 flox/flox mice x Ins1-Cre mice (https://www.jax.org/strain/026801) 
Third generation bred from VPS41 fl/fl x VPS41 fl/-, Ins1-Cre hemi used for experiments 
 
Glucose Tolerance Test 
Mice are fasted 5 hours, then analysed prior to IP-GTT by EchoMRI to calculate 
dose of 2mg/kg glucose to lean mass. Mice are tail tipped for basal blood glucose and 
insulin measurement, then injected with a 25% glucose solution in injectable water via 
intraperitoneal route. Blood is collected at 15 minutes for fed insulin measurement, and at 
the following timepoints: 15, 30, 45, 60, 90, 120, for glucose measurements.  
 
Static Islet Insulin Secretion 
Following islet isolation, islets recovered in recovery medium (RPMI, 10% FBS, 
11.1mM glucose) for 1hr @ 37C. 10 islets per well (in triplicate) placed into filter unit 
into KRB with no glucose. Filters with islets transferred to KRB solution containing 
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2.8mM glucose, as basal incubation, or 16.7mM glucose KRB, as stimulatory. Incubate 
@ 37C for 20min. Rinse the islets three times with zero glucose KRB. Incubate in low 
glucose KRB for 1hr. Islets lysed in acid-ethanol (75% ethanol / 1.5% HCl) overnight @ 
-20C. Secreted and cellular insulin content measured via ELISA.  
 
Fluorescent IHC  
Whole pancreas imbedded in paraffin, prior to thin sectioning. Thin section of 
pancreas are deparaffinized and rehydrated for 3min in following solutions: 2x xylene 
rinse solution, 1x 50% xylene / 50% ethanol, 1x 100% ethanol, 1x 95% ethanol, 1x 80% 
ethanol, 1x 75% ethanol, 1x 50% ethanol, 1x ddH2O. Wash slides 3min 2x in PBS with 
0.1% BSA, 0.01% NaN3. Block non-specific antibody association with 2 drops of 
blocking solution (DAKO). Dilute primary antibody in dilution buffer (DAKO), 100µl 
per section, and incubate overnight @4C in a humidified chamber. Wash slice 3x with 
wash buffer for 3min each. Dilute secondary antibody in dilution buffer, 100µl per slice, 
incubate @RT for 1hr. Rinse with wash buffer 2x for 3min. Rinse with PBS 2x for 3min. 




Unless indicated otherwise, all statistical analysis was performed using the two-





Images were processed using ImageJ; any changes in brightness and contrast were 























The HOPS complex component VPS41 specifically affects regulated insulin 
secretion in pancreatic β-cells.  
 In order to assess the potential role of the HOPS complex to insulin secretion, we 
performed siRNA knock-down (KD) of VPS39 or VPS41 in INS-1 cells. We validated 
the KD by examining a HOPS specific defect in endo-lysosomal fusion, which results in 
decreased EGF degradation. Specifically, we incubated our cells with fluorescently 
labeled EGF and looked at the remaining fluorescence after a 90 min chase. Both VPS39 
and VPS41 KD cells exhibited obvious fluorescence retention compared to control cells 
(Fig. S1A), suggesting that the siRNA treatments led to similar HOPS disruption. 
Surprisingly, analysis of VPS41 levels by western blot revealed that KD of VPS39 also 
decreased VPS41 protein levels (Fig. 5A). To test if this effect was due to instability of 
HOPS specific components in the absence of full HOPS assembly, we acutely treated 
VPS39 KD cells with the proteasome inhibitor, MG132, and observed a marked increase 
in VPS41 levels in presence of the inhibitor (Fig. S1C-D). In contrast, the same treatment 
showed no effect on control cells. These data strongly suggest that a pool of VPS41 
normally associated with HOPS becomes susceptible to degradation in the absence of 
complete HOPS assembly.  
 We next monitored insulin secretion from these cells via ELISA. We observed a 
significant decrease in both insulin content and stimulated secretion of insulin in VPS41 
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KD cells (Fig. 5B-D). Importantly, the levels of insulin mRNA determined by real-time 
qPCR remained unchanged, suggesting that the effect on insulin content is not a 
consequence of transcriptional changes (Fig. S1E). Strikingly, we found that, despite the 
significant decrease in VPS41 protein levels in VPS39 KD cells, these cells exhibited no 
defect in regulated insulin secretion. Taken together, we conclude that HOPS specific 
subunits rely in part on full complex assembly for stability, but that a stable pool of 
VPS41 can exist outside of HOPS and plays a role in storage and regulated secretion of 







Figure 5: INS-1 cells were transfected with indicated siRNAs. (A) Representative 
western blots showing the levels of VPS41. (B) Total cellular insulin levels under basal 
conditions. (C) Basal and stimulated insulin secretion from KO and rescue INS-1. (D) 
Secreted insulin in relation to total cellular content. (E) Fold stimulated secretion of 
insulin. Data indicate mean +/- s.e.m.; n=3  *: p < 0.05, **: p < 0.01, ****: p < 0.001  
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Generation of VPS41 KO INS-1 cells 
In order to further assess the contribution of VPS41 to insulin secretion, we 
generated VPS41 KO INS-1 cells using CRISPR/Cas9. The analysis of indels from 
genomic DNA isolated from these cells revealed the presence of two distinct single base 
pair insertions predicted to mutate the initiator codon (Fig. S2A,B). Consistent with this 
result, we could not detect VPS41 protein by western blot in lysates generated from these 
cells, even when using sensitive enhanced chemiluminescent reagents (Fig. 6A). As a 
control for potential Cas9 off-target effects, we generated a rescue line by stably 
reintroducing full-length VPS41 bearing a N-terminal HA tag (HA-VPS41) using a 
lentivirus. We confirmed that the expression level matched endogenous levels by western 
blot and that the expression of HA-VPS41 could indeed be detected in every cells by 
immunofluorescence against the epitope tag (Fig. 6A, Fig. S3A). As expected, these 
VPS41 KO cells exhibited impaired EGF degradation, consistent with a defect in late 
endosome/lysosome fusion caused by HOPS deficiency (Fig. S3B,C). 
 
VPS41 KO INS-1 cells show a defect in insulin secretion 
We next examined basal and stimulated insulin secretion from KO and rescue 
cells by ELISA and, consistent with the siRNA experiments, observed that lack of VPS41 
led to a significant decrease in stimulated insulin secretion as well as a substantial 
reduction in cellular insulin stores (Fig. 6B,C). Importantly, we still observed a defect in 
insulin secretion after normalizing secreted values to cellular stores (Fig. 6D) leading to a 
decrease in the fold stimulation over basal (Fig. 6E). Consistent with the ELISA results, 




Figure 6: (A) Representative western blots showing the levels of VPS41 in WT, 
VPS41 KO, and HA-VPS41 rescue INS-1 cells. (B) Total cellular insulin levels under 
basal conditions. (C) Basal and stimulated insulin secretion from KO and rescue INS-
1. (D) Insulin secretion relative to cellular insulin stores. (E) Fold stimulated insulin 
secretion over basal insulin secretion. Data indicate mean +/- s.e.m.; n=3  *: p < 0.05, 






























































































observed a decrease in total insulin signal in VPS41 KO cells by immunofluorescence, 
mostly due to peripheral depletion leading to a relative increase in perinuclear signal 
(Fig. S4A-C). As the insulin ELISA kit can also recognize proinsulin to some extent, we 
separately measured proinsulin levels in secreted and cellular fractions. VPS41 KO cells 
displayed slightly increased cellular stores of proinsulin (Fig. S5A). As a consequence, 
these cells show an increase in the ratio of cellular proinsulin over insulin (Fig. S5B). 
However, VPS41 KO cells showed no difference in proinsulin secretion (Fig. S5C-E). 
We conclude that VPS41 regulates insulin content and is required for the regulated 
release of insulin. 
 
The absence of VPS41 leads to changes in SG number and biochemical and 
morphological properties 
These results prompted us to further determine the biochemical properties of SGs 
in absence of VPS41. For this, we relied on equilibrium sedimentation through sucrose 
and determined insulin distribution within the gradient by ELISA. In VPS41 KO cells, 
insulin shifted to lighter fractions compared to rescue cells (Fig. 7A,B). To confirm that 
insulin containing fractions were in fact SGs, we determined the localization of an 
additional SG cargo, proprotein convertase 1/3 (PC1/3), by western blot and found that it 
co-sedimented with insulin in both VPS41 KO and rescue cells. Additionally, this effect 
appears to be specific to SGs, as synaptophysin (p38) sedimentation remained unaffected. 
Analysis of thin-sections by EM revealed that the absence of VPS41 decreases the 
number of SGs (Fig 7C). Altogether these data suggest that the absence of VPS41 affects 





Figure 7: Postnuclear supernatants (PNS) obtained from VPS41 KO and HA-VPS41 
rescue INS-1 cells were separated by equilibrium sedimentation through 0.6–1.6 M 
sucrose. Fractions were collected from the top of the gradient and assayed for (A) 
synaptophysin (p38) and proprotein convertase 1/3 (PC1/3) by quantitative 
fluorescence immunoblotting. The graphs (B) quantify the immunoreactivity in each 
fraction as a percentage of total gradient immunoreactivity from one experiment. 
Insulin levels for the same fractions were determined by ELISA. Similar results were 
obtained in an additional independent experiment. (C) Representative thin section EM 
images of VPS41 KO and HA-VPS41 INS-1 cells. Scale bar indicates 1 μm. (D) 
Quantification of total SGs per cell normalized to the area of the section. Data indicate 
























































biochemical properties of insulin SGs, suggesting that VPS41 might be required for more 
than one aspect of their biogenesis 
 
The absence of VPS41 leads to lysosome and autophagosome biogenesis, but does 
not lead to increased insulin degradation 
How does VPS41 influence insulin cellular stores? Lack of VPS41 could 
influence insulin turnover. Interestingly, the lysosomal mTOR complex (mTORC) 
regulates the levels of lysosomal and autophagosomal gene products (Puertollano 2014)). 
Specifically, inactivation of mTORC in response to cellular starvation leads to nuclear 
translocation of the transcription factor TFE-3, which directly activates lysosomal and 
autophagosomal gene expression. Interestingly, it was recently observed that loss of 
VPS41 in HeLa cells leads to a striking increase in lysosomal biogenesis (van der Welle 
et al, unpublished), indicating that defects in endolysosomal degradation due to HOPS 
deficiency mimic cellular starvation by activating TFE-3. We immunostained VPS41 KO 
and rescue INS-1 cells for TFE-3 and indeed observed an increase in constitutive nuclear 
localization of this transcription factor under non-starving conditions (Fig. 8A,B). 
Consistent with this, we detected an increase in the expression levels of lysosomal genes 
(lamp-1, cathepsin B) by real-time qPCR and by western blot (Fig. S6A-C). We also 
quantified the number of active lysosomes using Magic Red (MR), a membrane-
permeable dye that becomes fluorescent after cathepsin B activation, and found a 
significant increase in active lysosomal compartments in absence of VPS41 (Fig. 8C,D). 
We next tested whether this increase in lysosomal biogenesis could contribute to the 
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decrease in insulin content observed in absence of VPS41. However, we found that 
treatment with lysosomal hydrolase inhibitors for 24h had no effect on insulin content 
(Fig. 8E). Thus, although the lack of VPS41 triggers a response aiming at increasing 
lysosomal biogenesis, it does not lead to insulin degradation. In addition, we found that 
mature cathepsin D redistributed to lighter fractions in VPS41 KO cells by equilibrium 
sedimentation through sucrose (Fig 8F), suggesting differences in biochemical properties 
of these lysosomes, probably due to diminished flux of endocytic cargo. 
HOPS deficiency also leads to an accumulation of autophagosomes (Jiang et al 
2014). To test whether this phenomenon holds true in INS-1 cells, we transfected VPS41 
KO and rescue cells with LC3-eGFP and indeed found a striking increase in the number 
of LC3 positive compartments in VPS41 KO cells (Fig. 8G,H). However, we found a 
significant decrease in autophagic flux using a two color mCherry-eGFP-LC3B reporter 
(N’Diaye et al 2009) (Fig 8I,J). In addition, insulin did not colocalize with these stalled 
autophagosomes by immunofluorescence and by immuno-EM in the KO (Fig S6D). It is 
thus unlikely that a significant portion of insulin SGs gets engulfed into autophagic 
structures in absence of VPS41.  Altogether these data indicate that the lack of VPS41 
does not lead to missorting of insulin to autophagosomes or lysosomes.  
 
VPS41 KO cells display normal TGN budding kinetics, but show missorting of 
transmembrane proteins leading to constitutive insulin secretion 
We next tested whether the decrease in SG number observed in VPS41 KO cells 
could be a consequence of a budding defect from the TGN. For this, we relied on the 
RUSH system (Boncompain et al 2012) using a ER hook and biotin to release a 
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synchronized wave of SG cargo (NPY-GFP). Using live-imaging, we monitored the 
movement of NPY-GFP along the secretory pathway (Maslar et al, unpublished). Upon 
addition of biotin, NPY-GFP trafficked from the ER to the Golgi, followed by its 
incorporation into post-Golgi carriers in VPS41 KO and rescue cells. By measuring 
changes in fluorescence, we determined TGN exit rates and found that they remained 
unchanged between the two cell lines (Fig. 9A). These data suggest that the budding 
kinetics of soluble SG cargoes remain unaffected.  
After ruling out insulin degradation and budding defects as an explanation for the 
decrease in insulin content, we reasoned that the absence of VPS41 could lead to the 
formation of “malfunctioning” SGs, which are undergoing exocytosis constitutively and 
thus are not accumulating intracellularly. Interestingly, although we did not observe a 
statistical difference in basal insulin secretion when analyzed by ANOVA together with 
stimulated secretion data, VPS41 KO INS-1 cells exhibit a 50% increase in basal 
secretion compared to rescue cells, and this effect is significant by t-test (p = 0.0067) 
when compared directly. (Fig. 6B).  We next looked at the behavior of a transmembrane 
SG marker (phogrin) using RUSH (Maslar et al, unpublished) and observed a striking 
decrease in its colocalization with insulin after biotin addition in VPS41 KO cells. (Fig 
9B,C) This suggests that the absence of VPS41 affects SG protein composition, in 











































































































































Figure 8: (A) Representative images of TFE-3 immunostaining in VPS41 KO and HA-
VPS41 rescue INS-1 cells imaged by spinning disk confocal microscopy. (B) 
Quantification of the amount of total TFE3 within the nuclear compartment, as 
determined by DAPI staining. (C) VPS41 KO and rescue cells were exposed to the 
Cathepsin B cleavable dye, Magic Red, and imaged using a spinning disk confocal 
microscope. (D) Quantification of Cathepsin B Magic Red positive compartments. (E) 
Insulin levels were determined by ELISA from cell lysates incubated with hydrolase 
inhibitors. (F) PNS were separated by equilibrium sedimentation through 0.6–1.6 M 
sucrose. Fractions as described in Figure 3 and assayed for Cathepsin D (CatD). The 
graphs quantify the immunoreactivity in each fraction as a percentage of total gradient 
immunoreactivity from one experiment. Similar results were observed in an additional 
independent experiment. Insulin values from Figure 3 are shown as a reference. Cells 
transfected with LC3B-eGFP (G) or mCherry-eGFP-LC3B (I) were imaged for 
presence of LC3+ puncta. (H) Quantification of LC3-GFP + puncta in KO and rescue 
cells. (J) Percentage of of mCherry-LC3 positive puncta that also have unquenched 
GFP-LC3. Data indicate mean +/- s.e.m.; n=3 for LC3-GFP, n=3 for MR and n=3 for 2 
color LC3 *: p < 0.05,  ***: p < 0.001, ****: p < 0.0001. Scale bars: 10μm 
 
 
Loss of VPS41 leads to a defect in insulin granule exocytosis 
These data indicate that lack of VPS41 might affect SG release properties. To test 
whether the absence of VPS41 leads to an impairment in SG exocytosis, we transfected 
VPS41 KO and rescue cells with NPY-pHluorin and monitored exocytosis in real-time 
using spinning-disk confocal microscopy. Under basal conditions, we observed very few 
exocytosis events across the two cell lines, confirming that NPY-pHluorin does not mis-
sort to the constitutive secretory pathway in absence of VPS41. However, under 
stimulatory conditions, HA-VPS41 rescue cells showed a robust increase in the number 
of events (61 events/μm/sec (x10-4)), but this number was dramatically reduced in the KO 
cells (12 events/μm/sec (x10-4)) (Fig. 9D). Interestingly, we also found that the type of 
events remaining in the KO cells exhibited very different kinetics. Indeed, in rescue cells, 
the large majority of events (>80%) lasted less than 1s, but in the KO cells, 50% of 
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events went on for more than 1s, with some lasting up to 9s (Fig. 9E). Importantly, this 
exocytosis defect could not be explained by an impairment in the excitability of the cells 
as calcium imaging experiments revealed that VPS41 KO and rescue cells displayed 
similar responses following depolarization (Fig. 9F). In order to examine if these effects 
on stimulated exocytosis are evident directly after budding, we relied again on the RUSH 
system to look at NPY-pHluorin release properties at different times (2, 3, or 4h) after 
biotin addition. We observed a striking reduction in the number of events at each time 
point, but the defect tended to become more pronounced with time (Fig 9G,I). 
Interestingly, the effect on kinetics of exocytosis remained unchanged at 2h and became 
apparent only at later time points (Fig 9H,J). Altogether, these data suggest that the 
absence of VPS41 reduces the total number of SGs that are available for release and that 


















































































































































































Figure 9: (A) Representative Golgi decay curves of exit of NPY-eGFP from VPS41 
KO and HA-VPS41 INS-1 after induction of cargo wave via biotin addition. (B) 
Representative images of Phogrin-eGFP co-stained with insulin 24hrs post-biotin 
addition, Scale bars: 10μm. (C) Manders colocalization coefficent of phogrin 
colocalization with insulin signal in VPS41 KO and rescue (D) Quantification of NPY-
pHluorin exocytosis events in VPS41 KO and HA-VPS41 rescue INS-1 cells over a 
10s basal or stimulated period. (E) Cumulative frequency distribution of NPY-
pHluorin exocytosis event duration in VPS41 KO and rescue cells. (F) Quantification 
of calcium imaging (Fura) in response to depolarization (high K+) in KO and rescue 
cells. (G) Quantification of NPY-pHluorin exocytosis events in VPS41 KO and HA-
VPS41 rescue INS-1 cells over a 10s basal or stimulated period 2hrs post-biotin 
addition. (H) Cumulative frequency distribution of NPY-pHluorin exocytosis event 
duration in VPS41 KO and rescue cells 2hrs post-biotin addition. (I) Quantification of 
NPY-pHluorin exocytosis events in VPS41 KO and HA-VPS41 rescue INS-1 cells 
over a 10s basal or stimulated period 3hrs post-biotin addition. (J) Cumulative 
frequency distribution of NPY-pHluorin exocytosis event duration in VPS41 KO and 
rescue cells. .Data indicate mean +/- s.e.m.; n=3 *: ***: p < 0.001, ****: p < 0.0001 
Event number analyzed by one-way ANOVA. Event duration analyzed by 
Kolmogorov Smirnov. 
 
Human point mutation S285P rescues insulin secretion but not HOPS 
Human patients carrying a point mutation within VPS41 (S285P) exhibit 
neurological defects without any known endocrine dysregulation (van der Welle et al, 
unpublished). We reasoned that this point mutant could help distinguish between HOPS 
dependent and independent effects of VPS41. Thus, we stably expressed an HA tagged 
rat VPS41S284P (S285P equivalent) in VPS41 KO INS-1 cells and found that they 
displayed a defect in EGF degradation and LC3 puncta accumulation similar to VPS41 
KO cells (Fig 10A, S8A) (Fig S8 B,C), indicating a defect in HOPS. We next monitored 
insulin secretion from these cells and observed that this mutant completely rescues 
insulin secretion and storage (Fig. 10B-E). These data suggest that this mutation enables 






Figure 10: (A) Representative western blot showing VPS41 levels in WT, KO and KO 
expression of VPS41S284P-HA variant. (B) Total cellular insulin levels under basal 
conditions. (C) Basal and stimulated insulin secretion from KO and rescue INS-1. (D) 
Insulin secretion relative to cellular insulin stores. (E) Fold stimulated insulin secretion 
over basal insulin secretion. Data indicate mean +/- s.e.m.; n=3 *: p < 0.05, **: p < 




























































































Mice with beta-cell specific deletion of VPS41 show a defect in insulin secretion 
To explore the physiological role and significance of VPS41 in glucose 
homeostasis, we deleted VPS41 specifically in beta-cells of the pancreas by crossing 
mVam2 fl/fl animals with mice expressing Cre under the control of the insulin promoter  
(Aoyama et al 2012, Thorens et al 2015). Comparison of VPS41 protein levels in lysates 
prepared from isolated islets revealed a ~75% reduction in VPS41 KO mice (Fig S9 A-
C). Importantly, VPS41 levels remained unchanged in whole brain, hypothalamus and 
liver lysates, indicating that the deletion is specific (Fig S9A,B). VPS41 KO mice did not 
show any changes in body weight, fat or lean mass at 8 or 15 weeks (Fig. 11A, Fig. 
S10A), but these animals exhibited a dramatically higher fasting glycemia (~25mM) 
compared to age-matched controls (~10mM) (Fig. 11B, Fig S10B). We next performed a 
glucose tolerance test (GTT) on 8 weeks old animals and found that VPS41 KO mice are 
massively glucose intolerant (Fig. 11C). Additionally, we also observed a pronounced 
reduction in basal and glucose stimulated plasma insulin levels during GTT (Fig. 11D). 
At 15 weeks, VPS41 KO mice displayed an even more severe phenotype (Fig. S10C,D). 
Staining of whole pancreas sections by immunofluorescence revealed a significant 
reduction in insulin levels, but no apparent change in glucagon levels (Fig. 12A). Finally, 
we isolated islets from 15 week old animals and determined insulin secretion in vitro. 
Consistent with our data in INS-1 cells, we observed a dramatic defect in basal and 
glucose stimulated secretion from isolated islets (Fig. 12B, D), together with a reduction 





Figure 11: (A) Fat and lean mass measurements of age matched 8 week old WT and 
VPS41 KO mice. (B) Blood glucose measurement of mice fasted for 8hrs. (C) Blood 
glucose measurements during glucose tolerance test (GTT). (D) Circulating blood 
insulin levels before and after glucose injection. Data indicate mean +/- s.e.m.; KO 













































































Figure 12: (A) Representative immunofluorescence images of whole pancreas slices 
from VPS41 KO and WT mice stained for insulin (green) and glucagon (red). Scale bar 
shows 100μm (B) Stimulated insulin secretion from isolated islets under basal or high 
glucose conditions. (C) Islet insulin content normalized to DNA content, analyzed by t-
test. (D) Insulin secretion from isolated islets normalized to islet insulin concentration. 
Data indicate mean +/- s.e.m.; n=3  *: p < 0.05, **: p < 0.01,***: p < 0.001, ****: p < 































































Loss of VPS41 from neuroendocrine PC12 cells and neurons leads to defects in 
peptidergic regulated secretion. SGs can still form, but they show altered size, and 
morphology (Asensio et al 2013). Consistent with this previous work, we now show that 
VPS41 is similarly required for insulin secretion. Thus, although SGs display a wide 
range of size and cargo content across specialized secretory cells, some of the molecular 
mechanisms controlling their formation seem conserved between neurons, 
neuroendocrine and endocrine cells.  
The absence of VPS41 directly affects lysosomal function by disrupting HOPS 
function. This defect leads to an increase in lysosome and autophagosome biogenesis as 
demonstrated recently in non-secretory cells (van der Welle et al, unpublished). In 
agreement with this, we find that loss of VPS41 in INS-1 cells causes the expected defect 
in EGF degradation, together with a compensatory increase in active lysosomes and LC3 
positive compartments. This effect seems to be mediated by mTORC1 inactivation 
leading to nuclear translocation of TFE3. This observation in conjunction with the 
decrease in cellular insulin stores raises the concern that pleiotropic effects associated 
with loss of HOPS might indirectly affect insulin secretion, for example by increasing 
insulin degradation. However, we have performed several key experiments to exclude 
this possibility. First, incubation of VPS41 KO INS-1 cells with lysosomal inhibitors did 
not change cellular insulin content, and insulin does not accumulate in late endosomes, 
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lysosomes or autophagosomes by immunofluorescence or by immuno-EM. In addition, 
pathways such as autophagy and crinophagy, which could potentially deliver SGs to the 
lysosome for degradation, are inherently HOPS-dependent processes (Jiang et al 2014, 
Csizmadia et al 2017). These observations thus exclude lysosomal degradation as a 
mechanism responsible for the defect in insulin storage in VPS41 KO cells. Second, KD 
of VPS39 leads to a similar defect in EGF degradation and LC3 accumulation, but these 
cells exhibit no change in insulin regulated secretion. This suggests that the effect of 
VPS41 is specific and independent of HOPS. Finally, the S285P human mutation, which 
is unable to rescue HOPS function, restores insulin secretion completely, indicating that it 
is actually possible to isolate HOPS dependent and independent functions of VPS41.  
How does VPS41 mediate its effect on peptide hormone storage and regulated 
secretion? Although we can not yet determine the exact steps influenced by VPS41 
during SG biogenesis, our data suggest that VPS41 controls sorting of transmembrane 
proteins, which ultimately might influence SG release properties. We have previously 
proposed that VPS41 could function at the TGN during budding of SGs (Asensio et al 
2013) in neuroendocrine cells. Consistent with this, a pool of VPS41 localizes to the 
TGN (Pols et al 2013, Asensio et al 2013). Alternatively, VPS41 might be contributing to 
SG biogenesis by influencing maturation after budding. Interestingly, we have recently 
found that the large majority of newly-synthesized phogrin seems to be incorporated onto 
SG only after budding (Maslar et al, unpublished). Thus, it is tempting to speculate that 
retrograde pathways might contribute to SG maturation. Consistent with this, several 
cytosolic factors recently implicated in SG biogenesis seems to be typically associated 
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with the endocytic and retrograde pathways (Cattin-Ortola et al, unpublished, Topalidou 
et al, unpublished).  
Consistent with recent studies in non-endocrine cells (Sharma et al 2019), we 
observed that VPS39 KD leads to degradation of VPS41. Interestingly, a pool of VPS41 
remained stable, which raises the question of what confers the stability of this HOPS-
independent pool of VPS41. It is tempting to speculate that post translational 
modifications (PTMs) such as phosphorylation are responsible. In yeast, VPS41 
associates with two distinct compartments: AP-3 derived vesicles or the vacuole itself 
and this is mediated by phosphorylation of the membrane binding ALPS motif of VPS41 
(Cabrera et al 2010). In mammalian cells, VPS41 phosphorylation by p38alpha-MAPK 
has been shown to regulate HOPS recruitment to vLPS compartments to mediate their 
fusion with the lysosome (Barry et al 2012). It will be interesting to test, in the future, 
whether phosphorylation or other yet to identify PTMs regulates VPS41 stability.  
Interestingly, islets of BTBR mice, which are prone to develop diabetes, exhibit 
decreased levels of VPS41 gene expression (Keller et al 2008). In agreement with this, 
we now show that mice with a specific deletion of VPS41 in β-cells are overtly diabetic. 
Indeed, these animals display extreme fasting hyperglycemia and are glucose intolerant 
due to a defect in insulin secretion. Disruption of lysosome genes such as raptor (Ni et al 
2017) leads to a very similar phenotype, however, in this case, the defect in secretion 
seems to be linked to β-cell maturation and early onset decreases in β-cell mass. In 
contrast, we observe no obvious difference in islet size and morphology in absence of 
VPS41. The mouse phenotype thus indicates that VPS41 plays a significant role for 
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glucose homeostasis and normal physiology. Furthermore, our observation that the 
human mutation S285P is able to rescue the regulated secretory defect of VPS41 KO 
cells but not HOPS-specific phenotypes helps explain why patients bearing this mutation 
have no observable endocrine associated defects. It might also provide a rationale to 
explain why these patients are alive, whereas VPS41 full KO mice die during early 
embryogenesis (Aoyama et al 2012). Altogether, our data emphasize the physiological 
significance of understanding the mechanism of SG formation at the molecular level. 
Unraveling the role of cytosolic factors in this process could help reveal potential 




Figure 13: Model of VPS41 action in WT VPS41 (left) or VPS41 KO (right) cells. 
We propose that increased mis-sorting of transmembrane SG cargos leads to increased 
basal secretion events, which ultimately leads to downstream decreases in insulin 
storage as well as insulin SG release properties.  
VPS41 WT VPS41 KO
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Given what we know, we propose a model (Fig 13) wherein VPS41 may be acting at 
both the TGN, either as a coat protein (Asensio et al 2013) or in some other capacity 
potentially in conjunction with AP3, or in the post-Golgi maturation of SGs, potentially 
in maintaining the transmembrane identity of these granules. 
 Although the exact mechanism of VPS41 action in regulated secretion has not 
been elucidated here, we have opened several new avenues of potential research in order 
to get at this very question. Future work will focus on identifying the mechanism by 
which VPS41 is able to exist outside of HOPS, potential interacting partners in the 
regulated pathway, and at which stage in biogenesis (budding or maturation) these factors 
are playing a role in. VPS41 is predicted to be potentially ubiquitinated (Ubpred) at both 
the N- and C-terminus where it has been shown to interact directly with AP3 (Asensio et 
al 2013) and the HOPS complex (Hunter et al 2017). Perhaps the mechanism regulating 
the entry of VPS41 in this pathway is which of these sites is accessible for ubiquitination. 
To address this, we can deplete VPS39 from cells expressing VPS41, and look for sites of 
ubiquitination, in addition to other PTMs, in proteasome defective (MG132) cells via 
mass spectrometry proteomics. To identify potential protein partners for VPS41 within 
the regulated secretory pathway, we would propose to do proximity labeling (Kim et al, 
2016) of both WT VPS41 and the VPS41S284P patient mutant in both KO and KO 
depleted of VPS39 cells. We would anticipate that the patient mutation could potentially 
aid in identifying novel SG associated interacting partners, but its ability to associate with 
HOPS still might limit its relevance in this context (van der Welle et al, unpublished). 
When we prevent HOPS association via KD or KO of VPS39, we anticipate being able to 
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narrow in on the factors aiding in its HOPS-independent functions. In addition to this, 
another potentially interesting avenue of work could be to identify residues and domains 
of VPS41 regulating its interactions with the HOPS complex, which may give more 
insight into how VPS41 is differentially regulated. This could be achieved by performing 
a yeast-2-hybrid screen with mutant alleles of VPS41 generated via random mutagenesis. 
Although this is not a trivial task, it could potentially provide much needed insight into 
the role of these different VPS41 domain in its many different functions.  Finally, to 
identify which part of the pathway, budding or maturation, VPS41 is acting on, we are 
performing iEM of VPS41 in INS-1 cells to determine if VPS41 is localized to budding 
secretory granules at the TGN, post-Golgi SGs, or if it cannot be localized to either, 
suggesting a less directly mechanism of action. This could perhaps be improved upon, by 
increasing the relative pool of VPS41 that can effectively participate in this partway by 
KD or KO of VPS39. Overall the precise role of VPS41 in the regulated secretory 
pathway, and even outside of HOPS (Pols et al 2013), is still rife with opportunity and 
unexplored avenues of research. Advances in these mechanisms could help with targeted 
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Figure S1: (A) Representative images of EGF-647 labeled cells before or after a short 
(15min) or long (90min) chase. (B) Representative images of cells co-transfected with 
indicated siRNAs and LC3-eGFP. (C) siRNA treated cells incubated with 5μM MG132 
or DMSO for 12 hr prior to lysis and western blot analysis for VPS41 and tubulin. VPS41 
levels were normalized to tubulin expression and quantified (D) in comparison to their 








































































Figure S2: (A) PCRs from genomic DNA isolated from WT and VPS41 KO INS-1 cells 
show a band at 600bp representing sequence surrounding exon 1 of the rat VPS41 
sequence. (B) RNA guide sequence and predicted cleavage site for Cas9. Indels, both 
































Figure S3: (A) Representative images of VPS41 KO and HA-VPS41 rescue INS-1 
cells stained for HA. (B) Representative images of EGF-647 labeled cells before or 
after a short (15min) or long (90min) chase. (C) Quantification of the change in EGF-
647 fluorescence between 0 min and 90 min. Data indicate mean +/- s.e.m.; n=3 ***: p 









































Figure S4: (A) Representative images of INS-1 VPS41 KO or HA-VPS41 cells 
transfected with TGN-eGFP and stained for insulin. (B) Percentage of total insulin 
fluorescent signal localized within the masked Golgi region. (C) Total insulin 
immunoreactive fluorescent signal in VPS41 KO cells normalized to insulin signal in the 
HA-VPS41 rescue. Data indicate mean +/- s.e.m.; n=3 ***: p < 0.001, ****: p< 0.0001. 



































































Figure S5: (A) Total cellular proinsulin pool under basal conditions. (B) Total cellular 
ratio of proinsulin:insulin under basal conditions. (C) Basal and stimulated proinsulin 
release from VPS41 KO and rescue INS-1, analyzed by ANOVA. (D) Basal and 
stimulated proinsulin release from VPS41 KO and rescue INS-1 normalized to total 
cellular stores, analyzed by ANOVA. (E) Proinsulin secretion, fold stimulated release 













































































































Figure S6: (A) Level of expression of lysosomal gene products by qPCR of lysosomal 
genes (LAMP-1 and Cathepsin B). (B) Lysates from VPS41 KO and HA-VPS41 rescue 
INS-1 cells were immunoblotted using antibodies directed against the indicated proteins 
and quantified (C) and normalized to expression in the HA-VPS41 lysate. (D) 
Representative image of VPS41 KO cells stained for insulin after transfection with LC3-
GFP. Scale bars indicate 10 μm. Data indicate mean +/- s.e.m.;  n=3 *: P < 0.05, **: P < 































































Figure S7: (A) Quantification of NPY-pHluorin exocytosis events in VPS41 KO and 
HA-VPS41 rescue INS-1 cells over a 10s basal or stimulated period 3hrs post-biotin 
addition. (B) Cumulative frequency distribution of NPY-pHluorin exocytosis event 
duration in VPS41 KO and rescue cells. .Data indicate mean +/- s.e.m.; n=3 *: ***: p < 
0.001, ****: p < 0.0001 Event number analyzed by one-way ANOVA. Event duration 




























































Figure S8: Representative images of VPS41 KO and HA-VPS41 cells stained for 






































Figure S9: (A) Representative images of VPS41 KO and VPS41S284P-HA INS-1 rescue 
cells stained for HA. (B) Representative images of EGF-647 labeled cells before or after 
a short (15 min) or long (90 min) chase. (C) Representative images of INS-1 cells 


























Figure S10: (A) Representative western blots of VPS41 protein levels in various 
tissues from 15 week old age-matched WT or VPS41 KO mice. (B) GAPDH 
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Figure S11: (A) Fat and lean mass measurements of age matched 15 week old WT and 
VPS41 KO mice. (B) Blood glucose measurement of mice fasted for 8hrs. (C) Blood 
glucose measurements during glucose tolerance test (GTT) (D) Circulating blood 
insulin levels before and after glucose injection. Data indicate mean +/- s.e.m.; KO 
















































































Figure S12: (A) Fat and lean mass measurements of age matched 8 week old WT, Cre 
control, Vam2 fl/fl control, and VPS41 KO mice. (B) Blood glucose measurement of 
mice fasted for 8hrs. (C) Blood glucose measurements during glucose tolerance test 
(GTT) (D) Circulating blood insulin levels before and after glucose injection. Data 
indicate mean +/- s.e.m.; KO n=6, WT n=15  *: p < 0.05, **: p < 0.01,***: p < 0.001, 
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